MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11926-016-0583-y

Медицинская библиотека · Current rheumatology reports · 2016

SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Firinu Davide, Garcia-Larsen Vanessa, Manconi Paolo Emilio, Del Giacco Stefano R

СтатьяОбзорПеревод в очереди

Аннотация

SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is a rare autoimmune disease which, due to its clinical presentation and symptoms, is often misdiagnosed and unrecognized. Its main features are prominent inflammatory cutaneous and articular manifestations. Treatments with immunosuppressive drugs have been used for the management of SAPHO with variable results. To date, the use of anti-TNF-α agents has proved to be an effective alternative to conventional treatment for unresponsive or refractory SAPHO cases. TNF-α is a pro-inflammatory cytokine and pivotal regulator of other cytokines, including IL-1 β, IL-6, and IL-8, involved in inflammation, acute-phase response induction, and chemotaxis. IL-1 inhibition strategies with anakinra have shown efficacy as first and second lines of treatment. In this review, we will describe the main characteristics of biological drugs currently used for SAPHO syndrome. We also describe some of the promising therapeutic effects of ustekinumab, an antibody against the p40 subunit of IL-12 and IL-23, after failure of multiple drugs including anti-TNF-α and anakinra. We discuss the use and impact of the new anti-IL-1 antagonists involved in the IL-17 blockade, in particular for the most difficult-to-treat SAPHO cases.

Для цитирования: Firinu Davide, Garcia-Larsen Vanessa, Manconi Paolo Emilio, Del Giacco Stefano R. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.. Current rheumatology reports. 2016. DOI: 10.1007/s11926-016-0583-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.